logo
Select company
Select metric
32.53%Cash to Assets Ratio
VS
Market
85
Sector
60
Industry
48
History
57
$ 3.21Close
$ 2.68 - $ 6.09 52-Week Range
Ticker Information

Ticker

LPCN

Company Name

LIPOCINE INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LIPOCINE INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LPCN - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 18.58M$ 6.04M32.53%
3/31/2025$ 20.5M$ 3.35M16.36%
12/31/2024$ 22.51M$ 6.21M27.57%
9/30/2024$ 20.7M$ 3.74M18.08%
6/30/2024$ 23.03M$ 5.55M24.11%
3/31/2024$ 25.45M$ 3.08M12.11%
12/31/2023$ 23M$ 4.77M20.75%
9/30/2023$ 24.75M$ 4.07M16.45%
6/30/2023$ 30.48M$ 5.01M16.45%
3/31/2023$ 34.02M$ 4.77M14.02%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LIPOCINE INC's latest trailing twelve months (TTM) Cash to Assets stands at 72.47%.
  • Over the past 5 years, LIPOCINE INC's average Cash to Assets has been 23.78%.
  • The median Cash to Assets for LIPOCINE INC during this period was 16.45%
  • LIPOCINE INC reached its highest Cash to Assets over the past 5 years at 95.52%.
  • The lowest Cash to Assets recorded by LIPOCINE INC in the same timeframe 5.62%

LIPOCINE INC's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
MRKR : MARKER THERAPEUTICS INC 80%BOLT : BOLT BIOTHERAPEUTICS INC 13.76%TRAW : TRAWS PHARMA INC 83.73%NRXS : NEURAXIS INC 84.49%LGVN : LONGEVERON INC 61.7%XAIR : BEYOND AIR INC 18.28%DYAI : DYADIC INTERNATIONAL INC 48.84%INM : INMED PHARMACEUTICALS INC 71.09%LEXX : LEXARIA BIOSCIENCE CORP 68.11%INBS : INTELLIGENT BIO SOLUTIONS INC 12.36%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for LIPOCINE INC is calculated as follows: CashnEq [ $ 17.94M ] / Assets [ $ 24.75M ]
(=) Cash to Assets [ 72.47% ]

LPCN - Cash to Assets Ratio, Last 5 years

5.62%

Minimum

Dec 31, 2021

95.52%

Maximum

Dec 31, 2020

23.78%

Average

16.45%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.78% with a standard deviation of 9.53%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.76%
average9.78%
median6.42%
std9.53%